Biomarkers · 2010 · 73 citations · 21 references
MedicineNephrologyRenal PathologyRenal PathophysiologyRenal Replacement TherapyAcute Kidney InjuryRenal AssessmentRenal DiseaseRenal InflammationAcute Kidney Injury AssessmentAcute Kidney Injury DetectionAcute Kidney Injury DiagnosisBiomarker-based Early DetectionCase-control Study DesignEarly DiagnosisNested Case-control DesignPostoperative Acute Kidney Injury
The aim of this nested case-control study was to assess the combined use of urinary kidney injury molecule (KIM)-1 and interleukin (IL)-18 for acute kidney injury (AKI) after cardiopulmonary bypass surgery (CPB). From a cohort of 122 subjects who underwent CPB, serial urinary KIM-1 and IL-18 concentrations were determined in 30 AKI and 92 non-AKI patients. An increased level of urinary KIM-1 was associated with the occurrence of AKI, whereas an increased level of IL-18 was related to progressive AKI. The combination of these two biomarkers facilitates the early diagnosis and assessment of the likely progression of AKI after CPB.
21
Kidney Injury Molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury
Won Kon Han, Véronique Bailly, Rekha Abichandani et al. · Kidney International · 2002 · 1.9K citations · Full text
Medicine, Nephrology, Pathology +13
Acute renal failure: definitions, diagnosis, pathogenesis, and therapy
Robert W. Schrier, Wei Wang, Brian D. Poole et al. · Journal of Clinical Investigation · 2004 · 649 citations · Full text
Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease
Lowell J. Lo, Alan S. Go, Glenn M. Chertow et al. · Kidney International · 2009 · 571 citations · Full text
Medicine, Nephrology, Dialysis +13